TITLE

Relapse of Pneumocystis carinii pneumonia in the upper lobes during aerosol pentamidine prophylaxis

AUTHOR(S)
Bradburne, R M; Ettensohn, D B; Opal, S M; McCool, F D
PUB. DATE
July 1989
SOURCE
Thorax;Jul1989, Vol. 44 Issue 7, p591
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66123900

 

Related Articles

  • Pneumocystis carinii Pneumonia. Thomas, Simon; O'Doherty, Michael; Kateman, Nigel // BMJ: British Medical Journal (International Edition);1/27/90, Vol. 300 Issue 6719, p211 

    Focuses on the aerosolized pentamidine, a treatment directed against the site of the pneumocystis carinii pneumonia. Effects of aerosolized pentamidine; Study of the use of the treatment as a secondary prophylaxis; Factor that affects the efficacy of aerosolized pentamidine.

  • Digital Necrosis and Disseminated Pneumocystis carinii Infection after Aerosolized Pentamidine Prophylaxis. Davey Jr., Richard T.; Margolis, David; Kleiner, David; Deyton, Lawrence; Travis, William // Annals of Internal Medicine;10/15/89, Vol. 111 Issue 8, p681 

    Presents cases of patients who developed Pneumocystis carinii pneumonia following aerosolized pentamidine prophylaxis for HIV/AIDS treatment. Medical background of the patients; Treatment administered to the patients; Benefits from aerosolized pentamidine.

  • Intravenous or Inhaled Pentamidine for Treating Pneumocystis carinii Pneumonia in AIDS. Conte, John E.; Chernoff, David; Feigal Jr., David W.; Joseph, Pat; McDonald, Charles; Golden, Jeffrey A. // Annals of Internal Medicine;8/1/90, Vol. 113 Issue 3, p203 

    Evaluates the efficacy and toxicity of aerosolized pentamidine and of reduced-dose intravenous pentamidine for treating Pneumocystis carinii Pneumonia in patients with AIDS. Characteristics of patients receiving the treatment; Information on pentamidine pharmacokinetics; Correlation between...

  • Aerosol Pentamidine. Armstrong, Donald; Bernard, Edward // Annals of Internal Medicine;12/1/88, Vol. 109 Issue 11, p852 

    Discusses the efficacy of aerosol pentamidine for treatment of disease related to AIDS. Treatment and prevention of Pneumocystis carinii pneumonia; Differences between using pentamidine for prophylaxis and for treatment; Adverse reactions of the drug; Issue of whether aerosol pentamidine should...

  • Aerosol Pentamidine for Secondary Prophylaxis of AIDS-related Pneumocystis carinii Pneumonia. Montaner, Julio S.G.; Lawson, Lindsay M.; Gervais, Andre; Hyland, Robert H.; Chan, Charles K.; Falutz, Julian M.; Renzi, Paolo M.; MacFadden, Douglas; Rachlis, Anita R.; Fong, I.W.; Garber, Gary E.; Simor, Andrew; Gilmore, Norbert; Fanning, Mary; Taylor, Geoffrey D.; Martel, Alain Y.; Schlech, Walter F.; Schechter, Martin T. // Annals of Internal Medicine;6/1/91, Vol. 114 Issue 11, p948 

    Deals with a study which assessed the safety and efficacy of aerosol pentamidine for secondary prophylaxis of Pneumocystis (P.) carinii pneumonia in patients with AIDS. Review of related studies; Methods; Results and discussion.

  • Aerosolized Pentamidine: Effect on Diagnosis and Presentation of Pneumocystis carinii Pneumonia. Jules-Elysee, Kethy M.; Stover, Diane E.; Zaman, Muhammad B.; Bernard, Edward M.; White, Dorothy A. // Annals of Internal Medicine;5/15/90, Vol. 112 Issue 10, p750 

    Investigates the effect of aerosolized pentamidine therapy on diagnosis and presentation of Pneumocystis carinii pneumonia. Background on pneumocystis carinii; Diagnosis and pathology of the disease; Assessment of whether the severity of infection at presentation could have affected the...

  • Atovaquone Suspension Compared with Aerosolized Pentamidine for Prevention of Pneumocystis carinii Pneumonia in Human Immunodeficiency Virus-Infected Subjects Intolerant of Trimethoprim or Sulfonamides. Chan, Charles; Montaner, Julio; Lefebvre, Eric-Albert; Morey, Gary; Dohn, Michael; McIvor, R. Andrew; Scott, Janna; Marina, Raymond; Caldwell, Paul // Journal of Infectious Diseases;8/1/99, Vol. 180 Issue 2 

    Compares the atovaquone suspension and aerosolized pentamidine for the prevention of Pneumocystis carinii pneumonia (PCP) in HIV infection. Basis on the diagnosis of PCP; Correlation of low cell count with increase risk of PCP; Histology of Pneumocystis carinii organisms.

  • Improved Treatment For Pneumocystis. Helquist, Michael // Advocate;10/13/87, Issue 483, p23 

    Reports on the efficacy of aerosol pentamidine against pneumocystis carinii pneumonia in persons with AIDS. Absence of side effects; Reduction in average hospital stay.

  • Pentamidine for the Treatment of Pneumocystis carinii Pneumonia and Other Protozoal Diseases. Pearson, Richard D.; Hewlett, Erik L. // Annals of Internal Medicine;Nov85, Vol. 103 Issue 5, p782 

    Studies the therapeutic use of pentamidine for Pneumocystis carinii pneumonia and other protozoal diseases associated with AIDS. Pharmacology of pentamidine; Mechanism of action of pentamidine; Adverse effects of pentamidine.

  • Inhaled or Intravenous Pentamidine Therapy for Pneumocystis carinii Pneumonia in AIDS. Soo Hoo, Guy W.; Mohsenifar, Zab; Meyer, Richard D. // Annals of Internal Medicine;8/1/90, Vol. 113 Issue 3, p195 

    Compares inhaled pentamidine with intravenous pentamidine for the treatment of Pneumocystis carinii pneumonia in AIDS. Standard therapy for Pneumocystis carinii pneumonia; Toxicity associated with pentamidine therapy; Characteristics of patients in greater respiratory distress.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics